Pharmacy Times
FEBRUARY 16, 2024
This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.
STAT
FEBRUARY 16, 2024
Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
FEBRUARY 16, 2024
The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunothera | The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunotherapy developed by Iovance Biotherapeutics.
STAT
FEBRUARY 16, 2024
Two days after his right hand froze, Hart Bezner realized for the first time that he might lose it. The retired physics professor was sitting in an emergency room in Whitehorse, the capital of Canada’s Yukon territory, where two doctors and a pharmacist were taking an unusual amount of interest in the appendage and the pink blisters that now covered it.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
FEBRUARY 16, 2024
People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. | People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. The FDA has blessed Roche and Novartis’ Xolair as the first medicine to reduce allergic reactions that can occur with accidental exposure to certain foods.
STAT
FEBRUARY 16, 2024
Space is famously known as the final frontier for human exploration. It may also be the final frontier for human medicine. That’s what Dorit Donoviel, executive director of the Translational Research Institute for Space Health, and her team are working towards. TRISH is a consortium between Baylor College of Medicine, Caltech, and the Massachusetts Institute of Technology that partners with NASA to solve the health challenges of humans exploring deep space.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
FEBRUARY 16, 2024
Pharmacists can host community events and try different marketing efforts to drive community awareness about heart health and total health.
Fierce Healthcare
FEBRUARY 16, 2024
Nearly all healthcare executives believe new digital health technologies are worth the cost, even though they have yet to see a financial return from it, a new survey reveals. | Nearly all healthcare executives believe technology is worth the cost, even though they have yet to see a financial return from it, according to a new survey from EY. Most believe in its power to reduce costs and boost provider credibility.
STAT
FEBRUARY 16, 2024
Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program. Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s , according to new federal Medicare Advantage enrollment data analyzed by STAT.
Fierce Pharma
FEBRUARY 16, 2024
While Johnson & Johnson’s consumer health spinoff Kenvue prepares to move into a swanky new headquarters in Summit, New Jersey, it appears some staffers won’t be joining the company in the tran | While Johnson & Johnson’s consumer health spinoff Kenvue prepares to move into a new headquarters in Summit, New Jersey, it appears some staffers won’t be joining the company in the transition.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
FEBRUARY 16, 2024
Prominent immunologist and oncologist Padmanee Sharma defended herself in court on Friday against a lawsuit that alleges she threatened to undermine a junior faculty member’s career, made defamatory comments about the younger scientist, and attempted to take credit for work that she didn’t do. In legal filings submitted to the Harris County District Court, Sharma said that she made substantial contributions to an immunotherapy project that were ignored, and that a third-party asses
Fierce Pharma
FEBRUARY 16, 2024
A Novartis subsidiary in India has become the target of a strategic review as the Swiss pharma focuses its efforts on newer medicines. | A Novartis subsidiary handling old products in India has become the target of a strategic review as the Swiss pharma focuses its efforts on newer medicines.
pharmaphorum
FEBRUARY 16, 2024
CAR-T therapies can achieve remarkable efficacy in the treatment of haematological cancers, but the risk of side effects means that the cell infusions are almost always administered to inpatients under close supervision in clinics.
Drug Topics
FEBRUARY 16, 2024
Study results indicate that using salt substitutes can be a viable population-wide strategy in preventing cardiovascular disease and controlling hypertension.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
FEBRUARY 16, 2024
Recent biotech financings include a $245m raise for cancer blood test company Freenome, plus big rounds for Cogent Biosciences, BioAge Labs, Latigo Biotherapeutics, ProfoundBio, and Firefly Bio
Drug Store News
FEBRUARY 16, 2024
SOCi's Consumer Behavior Index shows consumers have little patience for online inaccuracies, including incorrect store hours, website information, contact details and more.
Fierce Healthcare
FEBRUARY 16, 2024
The effectiveness and safety of medication abortions obtained via telehealth are on par with those delivered in person, with no differences in outcomes between synchronous and asynchronous communic | Both synchronous and asynchronous approaches to medication abortion led to outcomes on par with in-person prescribing, a finding that addresses one of the key issues SCOTUS is scheduled to consider next month.
STAT
FEBRUARY 16, 2024
NEW YORK — Smoking has surpassed injecting as the most common way of taking drugs in U.S. overdose deaths, a new government study suggests. The Centers for Disease Control and Prevention called its study published Thursday the largest to look at how Americans took the drugs that killed them.
pharmaphorum
FEBRUARY 16, 2024
The ABPI has released a new guide on how the industry can support clinicians with prescribing decisions. Find out more about how pharmaceutical companies can assist healthcare professionals in providing optimal patient care.
Fierce Pharma
FEBRUARY 16, 2024
Four months after the FDA rejected Sanofi and Regeneron’s Dupixent to treat chr | Four months after the FDA rejected Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria, Japan’s health regulators have signed off on the drug in the indication.
Pharmacy Times
FEBRUARY 16, 2024
Taking a few seconds to double-check a prescription can have significant impacts on patient safety
STAT
FEBRUARY 16, 2024
Sonata Therapeutics, a startup created two years ago through the merger of two Flagship Pioneering companies, has laid off about a third of its staff. The biotech laid off 21 employees in recent weeks, according to employee posts on social media and a company spokesperson. Sonata had around 63 employees before the layoffs. Sonata is just the latest in a series of startups laying off employees in order to stretch out their cash runways.
pharmaphorum
FEBRUARY 16, 2024
Gilead Sciences has paused enrolment in clinical trials of its CD47 drug magrolimab in solid tumours, a week after dropping it for blood cancers.
Fierce Healthcare
FEBRUARY 16, 2024
The now chronic problem of more expensive agency staff and potentially lower quality care in nursing homes needs to be addressed as part of calls for increased oversight of the sector, according to | The now chronic problem of more expensive agency staff and potentially lower quality care in nursing homes needs to be addressed as part of calls for increased oversight of the sector, according to a recent academic study in Health Affairs.
pharmaphorum
FEBRUARY 16, 2024
Astellas has signed a deal with Kelonia Therapeutics that aims to push the boundaries of what can be achieved with CAR-T therapies in immuno-oncology
Pharmacy Times
FEBRUARY 16, 2024
One significant difference was an increased rate of bupropion prescriptions for transgender females.
pharmaphorum
FEBRUARY 16, 2024
Explore the role of artificial intelligence and machine learning in drug discovery and the challenges associated with patentability and predictability. Learn how AI is revolutionising the pharmaceutical industry.
STAT
FEBRUARY 16, 2024
A deal is never really done until it’s done. On Tuesday, two different proposed insurance plan acquisitions on different sides of the country called it quits — one of them for the second time. California-based Medicare Advantage insurer SCAN Group has been trying to buy CareOregon, an insurer offering coverage to half a million people in Oregon’s state health plan, since January 2023.
pharmaphorum
FEBRUARY 16, 2024
In this interview, Jonah Comstock speaks with Xavier Duportet, the founder and CEO of the biotech company, Eligo Bioscience, about the future of CRISPR gene editing at JP Morgan in 2024. Dive into the discussion to gain insights into this cutting-edge technology and its potential impact on the healthcare industry.
Fierce Healthcare
FEBRUARY 16, 2024
GoodRx is offering 30 common heart health medications for less than $30 at more than 70,000 pharmacies across the country. | Cardiovascular disease is the leading cause of death in the U.S. Thirty common generic and brand medications for heart health are now available across more than 70,000 U.S. pharmacies through GoodRx.
STAT
FEBRUARY 16, 2024
CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy. Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.
pharmaphorum
FEBRUARY 16, 2024
Patterns of behaviour: Using AI-based algorithms to improve outcomes for patients with atrial fibrillation Mike.
STAT
FEBRUARY 16, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, check in on the Pharmalot ancestors, and hold another listening party, where the rotation will likely include this , this , this , this and this.
Drug Store News
FEBRUARY 16, 2024
Cosset Bath & Body won the Drug Store News Buyersâ Choice Award for its Therapy Bombs and PurelifeBiotics was a finalist for its Shower Steamers.
Expert insights. Personalized for you.
144 
Let's personalize your content